Delta-Fly Pharma
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1080 Howe St, Vancouver, British Columbi...Phone Number
+81 362311278Website
www.delta-flypharma.co.jpRevenue
$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Delta-Fly Pharma
Delta-Fly Pharma Inc is a company that operates in the Pharmaceuticals industry. It employs 10to19 people and has 5Mto10M of revenue. The company is headquartered in Vancouver, British Columbia, Canada.Explore more
Delta-Fly Pharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Delta-Fly Pharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Delta-Fly Pharma has recently received funding, and reach out quickly before it becomes old news!
Check out if Delta-Fly Pharma is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Delta-Fly Pharma has new funding data
Delta-Fly Pharma, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Delta-Fly Pharma
Click to see if Delta-Fly Pharma had a recent Job posting/layoffs
Product Launch: Get notified when Delta-Fly Pharma launches new products
Earning: See what the market has to say on Delta-Fly Pharma recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Delta-Fly Pharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Delta-Fly Pharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Delta-Fly Pharma.
Delta-Fly Pharma Tech Stack
A closer look at the technologies used by Delta-Fly Pharma
Delta-Fly Pharma News & Media
Delta-Fly Pharma Inc.: Update for Development Status of DFP-17729
TOKUSHIMA, Japan--(BUSINESS WIRE)--We are excited to share our latest development status. We are pleased to announce that as a result of consultation with the PMDA on December 3rd, 2024, the Phase II/III clinical trial of DFP-17729 in combination with TS-1 versus TS-1 alone in patients with pancreatic cancer after third-line treatment was approved. In a Phase I/II study of DFP-17729 in combination with TS-1 in patients with end-stage pancreatic cancer, no significant difference was observedDelta-Fly Pharma Inc.: Progress Update of the Phase III Clinical Trial of DFP-14323
TOKUSHIMA, Japan--(BUSINESS WIRE)--We are excited to share our latest development status. Similar to its position in the United States, we are pleased to announce that Afatinib, which is being treated with DFP-14323 in our ongoing Phase III clinical trial, has been approved by the Japanese Lung Cancer Society in its “Lung Cancer Treatment Guidelines 2024” (issued on October 20, 2024) as a first-line treatment for EGFR mutation-positive (uncommon mutation) non-small cell lung cancer (NSCLC), witDelta-Fly Pharma Inc.: Update for Expanded Phase I Study of DFP-14927
TOKUSHIMA, Japan--(BUSINESS WIRE)--We are excited to share our latest development status. As informed dated October 28th, an interim analysis for the Phase III study of DFP-10917 in R/R AML patients is ongoing. The Phase I/II combination study of DFP-10917 with Venetoclax in AML patients is well ongoing. Today, we are delighted to talk about an update for development of the drug delivery of DFP-10917 selective to solid tumor, which is namely, DFP-14927 showed nice safetyDelta-Fly Pharma Inc.: Phase I/II Study of DFP-10917 and Venetoclax in AML Patients Begins with Promising Initial Data
TOKUSHIMA, Japan--(BUSINESS WIRE)--Following to the previous information on September 10th. 2024, we are excited to share our latest development status. Enrollment of patients is progressing smoothly into the Phase I portion of the Phase I/II study of DFP-10917 combined with Venetoclax in AML patients previously treated with Venetoclax, one regimen. The first three patients are showing encouraging safety and efficacy results suggested further promising development. The existing standard combina
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Delta-Fly Pharma
Sign Up For FreeTo access detailed company insights
Delta-Fly Pharma Inc is a company that operates in the Pharmaceuticals industry. It employs 10to19 people and has 5Mto10M of revenue. The company is headquartered in Vancouver, British Columbia, Canada.... Read More
